New data from Action on Smoking and Health (ASH) reveals a troubling public health disconnect requiring immediate prevention measures. With 7% of 11-17 year-olds currently vaping and misconceptions about harm rising dramatically, experts warn that delayed legislation is failing both children and adult smokers.

Stagnant Teen Usage Highlights Prevention Failures

The latest ASH research shows prevention efforts have stalled, with usage rates remaining unchanged from 2024. An estimated 1.1 million young people have tried vaping, whilst 400,000 currently use these products regularly. Daily vaping affects 160,000 children, representing 3% of the age group.

These persistent figures demonstrate that existing strategies have proven insufficient. Despite years of campaigning by health organisations, teen usage continues at levels that demand urgent legislative intervention through the delayed Tobacco and Vapes Bill.

Rising Harm Misperceptions Complicate Prevention Efforts

Public confusion about vaping risks has intensified, with 63% of young people now wrongly believing vaping equals or exceeds smoking’s harmfulness—a significant increase from 58% in 2024. Among adults, this misconception has risen from 50% to 56%, complicating both youth vaping prevention and smoking cessation programmes.

These misperceptions create barriers for adult smokers considering switching, with 26% never having tried vaping as a cessation tool. The proportion of smokers who’ve never vaped and consider it equally harmful as cigarettes has more than doubled from 27% in 2019 to 63% in 2025.

Legislative Delays Undermine Prevention Strategies

The Tobacco and Vapes Bill, introduced last November, remains stalled before House of Lords committee stage despite urgent youth vaping prevention needs. ASH Chief Executive Hazel Cheeseman describes the situation as “dangerous limbo,” where children remain exposed to appealing products whilst smokers face switching barriers.

Effective youth vaping prevention requires immediate regulatory powers to control product appearance, marketing, and sales strategies targeting young people. The legislation would enable banning brightly coloured packaging, restricting advertising, and limiting point-of-sale displays that appeal to minors.

Expert Calls for Comprehensive Prevention Framework

Professor Ann McNeill from King’s College London emphasises that persistent youth vaping levels continue to fuel public fears, which in turn tend to overshadow the potential role of vaping in helping smokers quit. She further warns that the lack of progress in reducing youth smoking—combined with the ongoing rise in vaping uptake—poses a significant public health concern that demands a more balanced and targeted intervention.

Meanwhile, Lord Faulkner of Worcester, a Labour peer and member of the APPG, adds to the urgency by calling for swift parliamentary action on the Tobacco and Vapes Bill. He specifically highlights youth vaping prevention as a key issue, describing the legislation as “a real opportunity to make lasting change for the better.”

Multi-Pronged Prevention Approach Required

ASH advocates for comprehensive youth vaping prevention measures including immediate committee stage scheduling, swift implementation following Royal Assent, and targeted marketing restrictions. Additionally, clear communication strategies must reinforce smoking’s greater harms whilst supporting programmes like Swap to Stop for adult smokers.

Professor Jamie Brown from UCL’s Tobacco and Alcohol Research Group highlights that stagnant adult vaping rates alongside rising harm misperceptions could slow smoking reduction progress. He emphasises that effective youth vaping prevention must not inadvertently discourage adult cessation attempts.

Healthcare Services Respond to Prevention Needs

Boots pharmacies have launched pilot stop-vaping services, recognising growing demand for cessation support. Meanwhile, NHS fertility treatment guidelines now consider smoking and vaping status for male partners, reflecting broader healthcare integration of substance use prevention approaches.

These developments demonstrate healthcare providers’ recognition that youth vaping prevention requires comprehensive support systems addressing both initiation prevention and cessation services for established users.

The ASH data underscores that without immediate legislative action and comprehensive youth vaping prevention strategies, the UK risks entrenching a generation of nicotine dependency whilst simultaneously undermining smoking cessation efforts among adults who could benefit from harm reduction approaches.

Source: dbrecoveryresources